ArticleFrontiers in pharmacology2021

The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment.

Lina Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.